De Novo AL Amyloidosis in Renal Allograft and Anti-CD38 Monoclonal Antibody Treatment

被引：1
|
作者：
Fotiou, Despina [1 ]
Skalioti, Chrysanthi [2 ]
Liapis, George [3 ]
Marinaki, Smaragdi [2 ]
Kastritis, Efstathios [1 ]
机构：
[1] Natl & Kapodistrian Univ Athens, Sch Med, Dept Clin Therapeut, Athens, Greece
[2] Natl & Kapodistrian Univ Athens, Laiko Hosp, Sch Med, Clin Nephrol & Renal Transplantat, Athens, Greece
[3] Natl & Kapodistrian Univ Athens, Laiko Hosp, Sch Med, Dept Pathol, Athens, Greece
来源：
HEMASPHERE | 2021年 / 5卷 / 12期
关键词：
DARATUMUMAB;
D O I：
10.1097/HS9.0000000000000665
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页数：3
相关论文
共 50 条
  • [11] Failure of mobilization of hematopoietic stem cells associated with elevated serum levels of anti-CD38 monoclonal antibody
    Seth, Abhishek
    Murray, David
    Buadi, Francis K.
    Gertz, Morie A.
    Yadav, Udit
    Kumar, Shaji K.
    Gonsalves, Wilson I.
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2023, 111 (02) : 318 - 321
  • [12] Considerations for pre-transfusion immunohaematology testing in patients receiving the anti-CD38 monoclonal antibody daratumumab for the treatment of multiple myeloma
    Quach, Hang
    Benson, Simon
    Haysom, Helen
    Wilkes, Anne-Marie
    Zacher, Nicole
    Cole-Sinclair, Merrole
    Prince, Henry Miles
    Mollee, Peter
    Spencer, Andrew
    Ho, Phoebe Joy
    Harrison, Simon J.
    Lee, Cindy
    Augustson, Bradley
    Daly, James
    INTERNAL MEDICINE JOURNAL, 2018, 48 (02) : 210 - 220
  • [13] Blood Transfusion Management for Patients Treated With Anti-CD38 Monoclonal Antibodies
    Lancman, Guido
    Arinsburg, Suzanne
    Jhang, Jeffrey
    Cho, Hearn Jay
    Jagannath, Sundar
    Madduri, Deepu
    Parekh, Samir
    Richter, Joshua
    Chari, Ajai
    FRONTIERS IN IMMUNOLOGY, 2018, 9
  • [14] Treatment of Multiple Myeloma in Patients Refractory to Daratumumab/Anti-CD38 Monoclonal Antibodies: A Systematic Review
    Tan, Chia Jie
    Kacerek, Dylan
    Kampirapawong, Nattawara
    Godara, Amandeep
    Chaiyakunapruk, Nathorn
    CANCER MEDICINE, 2025, 14 (05):
  • [15] Selection, Expansion, and Unique Pretreatment of Allogeneic Human Natural Killer Cells with Anti-CD38 Monoclonal Antibody for Efficient Multiple Myeloma Treatment
    Motais, Benjamin
    Charvatova, Sandra
    Walek, Zuzana
    Hrdinka, Matous
    Smolarczyk, Ryszard
    Cichon, Tomasz
    Czapla, Justyna
    Giebel, Sebastian
    Simicek, Michal
    Jelinek, Tomas
    Sevcikova, Tereza
    Sobotka, Jiri
    Koristek, Zdenek
    Hajek, Roman
    Bago, Juli R.
    CELLS, 2021, 10 (05)
  • [16] A Brief Report on Pre-Transfusion Testing in Patients Receiving the Anti-CD38 Monoclonal Antibody for Hematological Disorders in India
    Biswas, Durba
    Basu, Debapriya
    Nag, Arijit
    Kumar, Jeevan
    Datta, Suvro Sankha
    INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION, 2024, 40 (04) : 728 - 729
  • [17] Evolution of frontline treatment for multiple myeloma: clinical investigation of quadruplets containing carfilzomib and anti-CD38 monoclonal antibodies
    Costa, Luciano J.
    Gay, Francesca
    Landgren, Ola
    Mateos, Maria-Victoria
    Moreau, Philippe
    Touzeau, Cyrille
    Ertel, Franziska
    Mcfadden, Ian
    Najdi, Rani
    Weisel, Katja
    ANNALS OF HEMATOLOGY, 2025, : 1329 - 1351
  • [18] Pharmacy considerations: Use of anti-CD38 monoclonal antibodies in relapsed and/or refractory multiple myeloma
    Shah, Bhavesh
    Gray, Joy
    Abraham, Ivo
    Chang, Melody
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2023, 29 (01) : 170 - 182
  • [19] New method for overcoming the interference produced by anti-CD38 monoclonal antibodies in compatibility testing
    Castro Izaguirre, Emma
    del Mar Luis-Hidalgo, Maria
    Larrea Gonzalez, Luis
    Arbona Castano, Cristina
    BLOOD TRANSFUSION, 2020, 18 (04) : 290 - 294
  • [20] Hepatitis B reactivation in patients with multiple myeloma treated with anti-CD38 monoclonal antibody-based therapies: a pharmacovigilance analysis
    Moore, Donald C. C.
    Elmes, Joseph B. B.
    Arnall, Justin R. R.
    Strassels, Scott A. A.
    Patel, Jai N. N.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2023, 45 (06) : 1492 - 1495
12345